Latest News by Industry
LifeStance Health Group, Inc. [LFST] has reported a net loss of $186,262,000.0 for year ended Dec 31, 2023.
The Company said in a filing before the Securities and Exchange Commission that its total revenue for the year was $1.1 billion
Based in SCOTTSDALE, Arizona, LifeStance Health Group, Inc. operates in the SERVICES sector.
The consolidated Income Statement for the company for the 12 months ended December 31, for the years 2023, 2022, and 2021 is as follows:
- Total Revenue:
- 2023: $1.056 billion
- 2022: $859.542 million
- 2021: $667.511 million
- Operating Expenses:
- 2023: $1.245 billion
- 2022: $1.070 billion
- 2021: $953.864 million
- Loss from Operations:
- 2023: $(189.134) million
- 2022: $(210.174) million
- 2021: $(286.353) million
- Net Loss:
- 2023: $(186.262) million
- 2022: $(215.564) million
- 2021: $(307.197) million
- Net Loss Per Share, Basic:
- 2023: $(0.51)
- 2022: $(0.61)
- 2021: $(1.05)
- Net Loss Per Share, Diluted:
- 2023: $(0.51)
- 2022: $(0.61)
- 2021: $(1.05)
The company experienced an increase in total revenue from $859.542 million in 2022 to $1.056 billion in 2023, indicating positive growth in sales. However, operating expenses also increased from $1.070 billion in 2022 to $1.245 billion in 2023. This led to a reduction in the loss from operations from $(210.174) million in 2022 to $(189.134) million in 2023.
Despite the improvement in operational performance, the company still incurred a net loss of $(186.262) million in 2023, which was a decrease from $(215.564) million in 2022. The net loss per share for basic and diluted amounts also improved slightly from $(0.61) in 2022 to $(0.51) in 2023.
Overall, the company showed signs of progress in revenue generation and cost management, leading to a narrower net loss compared to the previous year.
USInMinutes/IndiaInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to more news alerts here. Although care is taken to ensure accuracy of the data, the article does not intend to replace user diligence while taking decisions of financial or legal implications